ARTICLE | Clinical News
DiaMedica preclinical data
August 9, 2010 7:00 AM UTC
In a delayed hypersensitivity model, a single dose of DM-99 significantly reduced skin inflammation by 67% vs. control (p<0.05). Furthermore, skin inflammation following a single dose of the undisclos...